Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cervical Cancer
Cervical cancer therapy with cisplatin appears comparable to other agents in same setting
March 23rd, 2006
Cervical cancer therapy with cisplatin appears to be comparable to other agents in the same setting. According to scientists at the University of California at Irvine, "This trial was conducted to evaluate the safety and efficacy of cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix." "All women had measurable histologically confirmed squamous cell cervical cancer and a GOG performance status {{<=}}2," explained C.A. Brewer and colleagues. "The women were to receive cisplatin at 30 mg/m2 plus gemcitabine at 800 mg/m2 day 1 and day 8 every 28 days. Between February 2001 and May 2002, 32...
Source: Women's Health Weekly (2006-03-23)
|
